chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Flushing, Nausea
Clinical narrative: Nausea; Chills; Extreme Fatigue; Body feels hot inside; Flushed Face; Dull ache on injection site; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 70-year-old female (non-pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6199, Pfizer NTEC), via an unspecified route of administration in right arm on 10Mar2021 1at 0:15 (at the of 70-year-old) as dose 1, single for covid-19 immunization. Medical history included chronic fatigue syndrome, fibromyalgia, type 2 diabetes, asthma and very sensitive to most medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other medication in 2 weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient experienced, nausea, chills, extreme fatigue, body feels hot inside, flushed face, dull ache on injection site on 10Mar2021 and ongoing for 19 days now. The adverse events resulted in physician office visit and emergency room visit. The patient did not receive any treatment. The clinical outcome for events was not recovered.  Follow-Up (15Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Nausea; Chills; Extreme Fatigue; Body feels hot inside; Flushed Face; Dull ache on injection site; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 70-year-old female (non-pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6199, Pfizer NTEC), via an unspecified route of administration in right arm on 10Mar2021 1at 0:15 (at the of 70-year-old) as dose 1, single for covid-19 immunization. Medical history included chronic fatigue syndrome, fibromyalgia, type 2 diabetes, asthma and very sensitive to most medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other medication in 2 weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient experienced, nausea, chills, extreme fatigue, body feels hot inside, flushed face, dull ache on injection site on 10Mar2021 and ongoing for 19 days now. The adverse events resulted in physician office visit and emergency room visit. The patient did not receive any treatment. The clinical outcome for events was not recovered.  Follow-Up (15Jul2021): Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: body aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route in the left arm on 24Mar2021 at 10:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications with two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), via an unspecified route in the left arm on 03Mar2021 at 14:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 at 22:30, the patient had body aches and chills starting about 12 hours after dose and this lasted through the night. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with ibuprofen (MANUFACTURER UNKNOWN) for the events body aches and chills. The clinical outcomes of the events body aches and chills were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Chills, Decreased appetite, Diarrhoea, Eructation
Clinical narrative: Nausea; Fatigue; Chills; Diarrhoea; 6lb weight loss within 24 hours; Constant burping; Bloating; Food taste bland; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8732) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient had allergies to lisinopril and losartan. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) and liraglutide (SAXENDA) weight loss injection. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 29Mar2021 at 18:30, the patient experienced nausea, fatigue, chills, diarrhea for at least 24 hours, 6lb weight loss within 24 hours, loss of appetite, food taste bland that normally the patient find good, constant burping and bloating. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic treatment was taken for the reported events. The clinical outcome of the events diarrhea recovered on 30Mar2021. The clinical outcome of the events nausea, fatigue, chills, diarrhea, 6lb weight loss within 24 hours, loss of appetite, food taste bland that normally find good, constant burping and bloating were not resolved at the time of this report.   No follow-up attempts are needed. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Taste disorder, Weight decreased
Clinical narrative: Nausea; Fatigue; Chills; Diarrhoea; 6lb weight loss within 24 hours; Constant burping; Bloating; Food taste bland; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8732) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient had allergies to lisinopril and losartan. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) and liraglutide (SAXENDA) weight loss injection. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 29Mar2021 at 18:30, the patient experienced nausea, fatigue, chills, diarrhea for at least 24 hours, 6lb weight loss within 24 hours, loss of appetite, food taste bland that normally the patient find good, constant burping and bloating. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic treatment was taken for the reported events. The clinical outcome of the events diarrhea recovered on 30Mar2021. The clinical outcome of the events nausea, fatigue, chills, diarrhea, 6lb weight loss within 24 hours, loss of appetite, food taste bland that normally find good, constant burping and bloating were not resolved at the time of this report.   No follow-up attempts are needed. No further information expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular, Rash pruritic
Clinical narrative: Rash spots arms, legs, feet and itchy; Rash spots arms, legs, feet and itchy; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in right arm on 21Mar2021 at 13:30 (at the age of 47-years old) as a single dose for COVID-19 immunisation. Medical history included lactose/ gluten intolerance and known allergy with penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medications within two weeks of vaccination. On 22Mar2021, the patient experienced rash spots on arms, legs, feet and itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events rash spots on arms, legs, feet and itchy was not resolved at the time of this report.   No follow-up attempts are needed Information about lot number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Fatigue, Paraesthesia
Clinical narrative: Dizziness/faintness; Cold sweat; Tingling in left arm; Fatigue; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old non pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via unspecified route of administration in the left arm on 24Mar2021 at 16:30 (at the age of 51-years-old) as single dose for COVID-19 immunisation. Medical history included eosinophilic esophagitis. The patient did not had allergies to medications, food, or other product. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX) of 40 mg and ibuprofen (ADVIL) received on unspecified dates for unknown indications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 24Mar2021 at 16:45, the patient experienced sudden onset of dizziness/faintness and cold sweat approximately 15 min after receiving shot, while waiting in monitoring area, tingling in left arm and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for adverse events. The clinical outcome of dizziness/faintness, cold sweat, tingling in left arm and fatigue were recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: Left armpit hurts; feels like a golfball size knot; This is a spontaneous report from a contactable other health care professional, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had allergy to sulfa drugs. Concomitant medication included sertraline (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 07:00, the patient experienced left armpit hurts and felt like a golf ball size knot. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events armpit hurts and felt like a golf ball size knot were not recovered at the time of this report.  Information about lot/batch number cannot be obtained; No follow-up attempts are needed;
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Tinnitus
Clinical narrative: Muscle aches next day after injection 2; Tinnitus lasting 4 hours began 1 hour after injection; Washed out feeling; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated blood pressure. The patient had known allergies to medications, food, or other products. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 05Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 13:30, the patient experienced tinnitus lasted 4 hours began 1 hour after the vaccination and muscle aches next day after injection 2. The patient had washed out feeling lasted day one and day two after the second injection. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tinnitus was resolved on 26Mar2021, washed out was resolved on 27Mar2021 and muscle ache was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Minor rash on left arm between wrist and elbow.Rash went away in that area but moved to elbow area, but much smaller area.; This is a spontaneous report from a contactable other health care professional, the patient. A 73-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 00:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergies from an unknown date. The patient had known allergies to medications, food, or other products which are unspecified. Concomitant medication included LOTS for an unknown indication from an unknown date taken within 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. one day after the vaccination on 26Mar2021 at 00:00, the patient experienced minor rash on left arm between wrist and elbow, rash went away in that area but moved to elbow area, but much smaller area. The patient did not receive any treatment for the events. The clinical outcome of the event rash on left arm between wrist and elbow was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: fatigue lasting 4 days and counting, headache, nausea,; headache; nausea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch no: FR8730) via unspecified route of administration in the left arm on 26Mar2021 at 10:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine headaches. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), erenumab (AIMOVIG), simvastatin (MANUFACTURER UNKNOWN) and mirabegron (MYRBETRIQ); all from unspecified dates for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch no: EN6206) via unspecified route of administration in the left arm on an unspecified date in Mar2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 06:00, the patient experienced fatigue that lasted 4 days and counting, headache and nausea. No therapeutic measures were taken for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, headache and nausea were recovered with sequalae.   No follow-up attempts needed. No further information expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rheumatoid arthritis
Clinical narrative: flared up on the day 6-7 after the vaccination. It used to be local in two joints and now I am flared up all over my body; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Mar2021 at 10:30 (at 36 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included rheumatoid arthritis (RA) from unspecified date. The patient had no known allergies. Concomitant medications included methotrexate, prednisone, and etanercept (ENBREL); all from unspecified date for unspecified indication. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. The patient reported her RA that had been pretty much in remission flared up on the day 6-7 after the vaccination. It used to be local in two joints and now she was flared up all over her body. She did not see any other reason apart from the vaccination. Start date of the adverse event was 27Mar2021. The event resulted in physician office visit. No treatment received for the event. Outcome of the event was not recovered.  Information about batch/lot number has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Headache, Lethargy, Neck pain
Clinical narrative: Body aches; Neck pain; Painful head; Fever/  lowest 99.9, highest 101.4; extremely cold extremities; lethargic; This is a spontaneous report from contactable consumer, the patient. A 63 years old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration on left arm on 24Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included Hypertension, hypothyroid, obesity and collagenous colitis. Concomitant medication included famotidine (MANUFACTURER UNKNOWN), torsemide (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), methylcellulose (CITRUCEL), vitamins nos, minerals nos (CENTRUM) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration on left arm on 03Mar2021 at 13:45 (at the age of 63 years old) as a single dose for COVID-19 immunisation, also received MACROBID and was allergic to it. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021 at 09:00, patient experienced body aches including neck and head more painful to hold up head, fever at (lowest 99.9 range and highest 101.4 range), extremely cold extremities in hands and feet this lasted for 36 hours. lethargic lasted for 3 days and total of 5 days. The lab data on 25Mar2021 included body temperature and ranges between lowest 99.9 and highest 101.4. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken for the adverse events. The clinical outcome for the events cold extremities recovered on 26Mar2021 at 21:00, while the event of lethargy was recovered on 27Mar2021, while the events body aches, neck pain, head pain, fever, cold extremities in hands and feet was recovered on 30Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Pyrexia
Clinical narrative: Body aches; Neck pain; Painful head; Fever/  lowest 99.9, highest 101.4; extremely cold extremities; lethargic; This is a spontaneous report from contactable consumer, the patient. A 63 years old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration on left arm on 24Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included Hypertension, hypothyroid, obesity and collagenous colitis. Concomitant medication included famotidine (MANUFACTURER UNKNOWN), torsemide (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), methylcellulose (CITRUCEL), vitamins nos, minerals nos (CENTRUM) for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration on left arm on 03Mar2021 at 13:45 (at the age of 63 years old) as a single dose for COVID-19 immunisation, also received MACROBID and was allergic to it. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021 at 09:00, patient experienced body aches including neck and head more painful to hold up head, fever at (lowest 99.9 range and highest 101.4 range), extremely cold extremities in hands and feet this lasted for 36 hours. lethargic lasted for 3 days and total of 5 days. The lab data on 25Mar2021 included body temperature and ranges between lowest 99.9 and highest 101.4. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken for the adverse events. The clinical outcome for the events cold extremities recovered on 26Mar2021 at 21:00, while the event of lethargy was recovered on 27Mar2021, while the events body aches, neck pain, head pain, fever, cold extremities in hands and feet was recovered on 30Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting; This is a spontaneous report received from a contactable consumer, the patient. A 20-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications of the patient included fluoxetine hydrochloride (PROZAC), cyproheptadine (MANUFACTURER UNKNOWN) and birth control from an unknown date and for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021, the patient experienced vomiting. The patient did not receive any treatment for the reported event. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vomiting was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Influenza like illness, Vertigo, Visual impairment
Clinical narrative: Extreme fatigue; Low grade flu symptoms; Vertigo; Dizziness; Vision effected; This is a spontaneous report from a contactable consumer, patient. A 54-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included hydrochlorothiazide (HTCZ) (MANUFACTURER UNKNOWN), bimatoprost (LATISSE), magnesium (MANUFACTURER UNKNOWN), commiphora mukul, piper longum, terminalia bellirica, terminalia chebula (TRIPHALA GUGGULU), melissa officinalis extract and origanum vulgare extract (MELATON). The patients had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 at 15:00 after 4.5 hours post shot, the patient experienced extreme fatigue, then low-grade flu symptoms. The patient felt like she was coming down with something. It was reported as two days out, the patient experienced vertigo, dizziness and vision was affected. The events vertigo and dizziness had continued till 30Mar2021 (third day). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the reported events. The clinical outcome of the events fatigue, low-grade symptoms, vertigo, dizziness and vision affected were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Gait disturbance, Muscle spasms, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8733) via an unspecified route of administration in the left arm in Mar2021 at 13:30 (at the age of 51-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6206) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 51-years-old) as single doses for COVID-19 immunisation. Medical history included asthma. The patient did not have any allergies to food, medications, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 09:00, about week after the first dose, the patient had cramping and a lot pain up and down the legs. For example, when the patient sat, it was hard to stand and legs were almost petrified. When the patient walked it was sore and painful. This lasted for about 4 to 5 days. After the second dose, the morning after it started again and was actually worst than previous time. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events cramp legs, leg pain, difficulty in standing and difficulty in walking. The clinical outcomes of the events cramp legs, leg pain, difficulty in standing and difficulty in walking were unknown at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Increased appetite
Clinical narrative: Increased appetite; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 14:15 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The facility where the patient received the vaccine was at a pharmacy or drug store. On 28Mar2021 at 15:00, the patient experienced increased appetite for 12 hours. The patient did not receive any treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event increased appetite was recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Headache, Nausea, Pyrexia
Clinical narrative: Fever; Chills; Nausea; Loss of appetite; Taste altered; Headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er26213) via an unspecified route of administration in the arm left on 19Mar2021 at 14:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any concomitant medications. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 18:00, the patient experienced fever, chills, nausea, loss of appetite, taste altered and headache. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, loss of appetite, taste altered and headache was recovered in Mar2021 (unspecified date).  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: Fever; Chills; Nausea; Loss of appetite; Taste altered; Headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er26213) via an unspecified route of administration in the arm left on 19Mar2021 at 14:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any concomitant medications. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 18:00, the patient experienced fever, chills, nausea, loss of appetite, taste altered and headache. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, loss of appetite, taste altered and headache was recovered in Mar2021 (unspecified date).  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Headache, Injection site pruritus, Pruritus, Rash
Clinical narrative: Very swollen injection site; red at injection site; hot and sore at injection site; Rash on upper body; vaccination site itching; Upper body itching; Sick to stomach; bad headache; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration, in the left arm on 29Mar2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and depression. Allergies to medications, food or other products included peanut, peanut by products, thimerosal, penicillin and amoxicillin allergy. Concomitant medications received within 2 weeks of vaccination included lamotrigine (LAMICTAL), venlafaxine hydrochloride (EFFEXOR), calcium (MANUFRATURER UNKNOWN) and vitamin D (MANUFRATURER UNKNOWN) all were from unknown date and for unspecified indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not get any other vaccine within 4 weeks of COVID-19 vaccine. On 29Mar2021, at 20:00 the patient experienced very swollen, red, hot and soreness at injection site. Rash on upper body that has started on last night and hasn't get better. The patient also reported itches on upper body and around injection site, and stomach discomfort and bad headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of the events very swollen, red, hot and sore at injection site, rash and itches on upper body, itches around injection site, stomach discomfort and headache were not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Very swollen injection site; red at injection site; hot and sore at injection site; Rash on upper body; vaccination site itching; Upper body itching; Sick to stomach; bad headache; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration, in the left arm on 29Mar2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and depression. Allergies to medications, food or other products included peanut, peanut by products, thimerosal, penicillin and amoxicillin allergy. Concomitant medications received within 2 weeks of vaccination included lamotrigine (LAMICTAL), venlafaxine hydrochloride (EFFEXOR), calcium (MANUFRATURER UNKNOWN) and vitamin D (MANUFRATURER UNKNOWN) all were from unknown date and for unspecified indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not get any other vaccine within 4 weeks of COVID-19 vaccine. On 29Mar2021, at 20:00 the patient experienced very swollen, red, hot and soreness at injection site. Rash on upper body that has started on last night and hasn't get better. The patient also reported itches on upper body and around injection site, and stomach discomfort and bad headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of the events very swollen, red, hot and sore at injection site, rash and itches on upper body, itches around injection site, stomach discomfort and headache were not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site swelling
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 62-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 26Mar2021 at 15:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, type 2 diabetes mellitus, psoriatic arthritis and possibly sulfonamide allergy. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 27Mar2021 at 08:00, the patient experienced swelling, lump, redness and pain where the vaccine was administered. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling, lump, redness and pain were not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cognitive disorder, Diarrhoea, Headache, Oropharyngeal pain
Clinical narrative: sore arm; headache; brain fog; sore throat; middle of the night stomach cramps; vomiting; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EIL8732), via an unspecified route of administration in the left arm on 28Mar2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to codeine. The concomitant medications included atomoxetine hydrochloride (STRATTERA), ethinylestradiol, etonogestrel (NUVARING), amlodipine (MANUFACTURER UNKNOWN) for unknown indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021 at 23:45, the patient experienced sore arm, headache, brain fog, sore throat, middle of the night stomach cramps, vomiting, diarrhoea. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events sore arm, headache, brain fog, sore throat, middle of the night stomach cramps, vomiting and diarrhoea were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: sore arm; headache; brain fog; sore throat; middle of the night stomach cramps; vomiting; diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EIL8732), via an unspecified route of administration in the left arm on 28Mar2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to codeine. The concomitant medications included atomoxetine hydrochloride (STRATTERA), ethinylestradiol, etonogestrel (NUVARING), amlodipine (MANUFACTURER UNKNOWN) for unknown indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021 at 23:45, the patient experienced sore arm, headache, brain fog, sore throat, middle of the night stomach cramps, vomiting, diarrhoea. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events sore arm, headache, brain fog, sore throat, middle of the night stomach cramps, vomiting and diarrhoea were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Pyrexia
Clinical narrative: Dizziness; fever; numbness; This is a spontaneous report from a contactable consumer, the patient. A 24-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Er8733) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6206) via an unspecified route of administration in the left arm on 04Mar2021 at 09:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not reported if the patient was allergic to medications, food, or other products. The patient experienced fever, numbness, dizziness on 30Mar2021 at 06:15. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.   Clinical outcome of fever, dizziness, numbness was unknown at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: Achy left arm; fingers (left) feel tingly and almost numb; finger almost numb; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: PFIZEREP7534); via an unspecified route of administration in the left arm on 15Mar2021 at 08:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other medications within two weeks prior to the COVID vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 07:00, the patient experienced achy left arm very painful to sit, to lay in bed or drive (pain felt like it hit his funny bone). The patient experienced fingers (left) tingly and almost numb. The arm pain started 3 days after the first dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit/ emergency visit/ department or urgent care. Therapeutic measures were taken as a result of pain in arm, tingling and numbness and included ibuprofen, cyclobenzaprine and naproxen. The clinical outcome of the events pain in arm, tingling and numbness were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Axillary pain, Contusion, Lymphadenopathy, Peripheral swelling
Clinical narrative: Left arm bruised; Left arm swollen; Left underarm swollen; Left underarm painful; Left side to waist swollen; Left side to waist painful; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 27Mar2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto disease, COVID-19, anxiety due to COVID illness and COVID-19 anosmia. Allergies to medications included ampicillin and penicillin. Concomitant medications received within 2 weeks of vaccination included levothyroxine (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and sambucus nigra (ELDERBERRY). Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 29Mar2021, the patient experienced events of bruise in left arm, swollen left arm, swollen left underarm, painful left underarm, left sided swelling to waist, left sided pain to waist. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of events bruise in left arm, swollen left arm, swollen left underarm, painful left underarm, left sided swelling to waist, left sided pain to waist was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.